Statues of Baltimore Black Sox players coming to waterfront development

Statues of Baltimore Black Sox players will be erected in the new Westport Waterfront Park to honor the history of the Negro ...

Mayor Scott signed 29 bills this week. Here’s what will change in Baltimore.

Baltimore is making some of its biggest policy bets in years on how the city grows, redevelops vacant properties, and raises ...
WBAL-TV on MSN

Orioles, UA surprise youth baseball player with custom cleats

A youth baseball player received a big surprise that will help him be the best he can be. During a pregame ceremony at ...

Baltimore County schools pick Heiser, not Sovine, as new superintendent

The Baltimore County Board of Education voted to appoint William Heiser as its next schools superintendent. Outgoing WCPS ...

Does footage show Albanians protesting Jared Kushner's island development project?

In June 2026, Albanians protested government corruption and issues of land access.
AFRO American Newspapers

City leaders propose charter amendment to modernize Baltimore water system

Baltimore city leaders introduced a charter amendment that would separate the Bureau of Water and Wastewater from the Department of Public Works in an effort to modernize the region’s aging water ...

Central Maryland Chamber of Commerce

Discover the latest press releases from Central Maryland Chamber of Commerce with the Baltimore Business Journal's BizSpotlight ...

For the Orioles, getting back to fundamentals starts from the ground up

The Orioles had reached a breaking point. One that had Mike Elias calling for the organization to take a hard look in the ...

Graduate from Maryland's Johns Hopkins University joins NASA's Artemis III crew

A graduate of Johns Hopkins University in Baltimore is joining NASA's 2027 Artemis III crew as a mission specialist.

Elixirgen Therapeutics and Nippon Shinyaku Enter into an Option Agreement for the Development and Commercialization of EXG-7001 for Duchenne Muscular Dystrophy

About Elixirgen Therapeutics, Inc. Elixirgen Therapeutics, Inc. is a clinical-stage biotechnology company developing treatments for rare diseases and aging-associated diseases using its ZSCAN4 ...